MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-18-0231233
Atilus Pharma Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹8.68 Cr
▼ 20% YoY
Net profit · FY 2025
₹72.35 Lakh
Net margin 8.3%
EBITDA · FY 2025
₹1.07 Cr
EBITDA margin 12.3%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹20 Lakh
Secured borrowings
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
About Atilus Pharma Private Limited
Data last updated:
Atilus Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 August 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24110MH2020PTC344095. Its GSTIN is 27AATCA8813D1ZG (Maharashtra). The company holds 3 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Lomesh Vinod Shah and Niraj Vinod Shah.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Gala No.C – 168 1st Floor Akurli Industrial Estate Akurli Road Kandivali (East), Mumbai, Maharashtra, India – 400101.
As per the financials filed for FY 2025, the company reported a revenue of ₹8.68 Cr, a decline of 20% compared to the previous year. For the same year it recorded a net profit of ₹72.35 Lakh (net margin 8.3%) and EBITDA of ₹1.07 Cr (EBITDA margin 12.3%). Revenue has declined at a compounded annual rate (CAGR) of 1% over three years.
The company is associated with 1 brand: Atilus Pharma. As per MCA filings, the company has open charges of ₹20 Lakh on record. Court records list 7 cases involving the company, including 7 filed against it; 2 cases are pending.
Atilus Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-18-0231233). For more details, the company can be reached via its website atiluspharma.com.
Company details
CIN U24110MH2020PTC344095
Registration Number 344095
Incorporation Date 19 August 2020
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MH-18-0231233
Recognitions & Rankings of Atilus Pharma
Contact details
Atilus Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its website is atiluspharma.com. Its e-mail address is in the company report.
- Email
- Website
- Social Media
- Registered AddressGala No.C – 168 1st Floor Akurli Industrial Estate Akurli Road Kandivali (East), Mumbai, Maharashtra, India – 400101
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Atilus Pharma Private Limited, buy the company report.
Comprehensive company report
Atilus Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Atilus Pharma operates one associated brand: Atilus Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| API manufacturing and supply in the healthcare sector from Mumbai, India. | atiluspharma.com |
Business activity
The main business activities of Atilus Pharma are manufacturing and trade. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and wholesale trading. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Atilus Pharma Private Limited, buy the company report.
Financials of Atilus Pharma Private Limited
FY 2025 filings availableAtilus Pharma Private Limited reported revenue of ₹8.68 Cr (down 20% YoY) for FY 2025.
Revenue · FY 2025
₹8.68 Cr ▼ 20%
Net profit · FY 2025
₹72.35 Lakh margin 8.3%
EBITDA · FY 2025
₹1.07 Cr margin 12.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 20%
3 years · compounded
▼ 1%
EBITDA CAGR growth
1 year
▼ 19%
3 years · compounded
▼ 10%
Revenue has declined at a compounded annual rate (CAGR) of 1% over three years, including a 20% fall in the latest year. EBITDA fell 19% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.07 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹72.35 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 12.3% | ||||
| Net Profit Margin | 8.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Atilus Pharma Private Limited, buy the company report.
Board of directors of Atilus Pharma Private Limited
Atilus Pharma has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Lomesh Vinod Shah | Director | 19 Aug 2020 | 6 Years 2 Months | Current |
| Niraj Vinod Shah | Director | 19 Aug 2020 | 6 Years 2 Months | Current |
Peer comparison
Atilus Pharma Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Aps Biotech Private Limited | ₹8.72 Cr (FY 2024) | 0.0% | Roorkee, Uttarakhand, India | |||
| Atilus Pharma Private Limited this company | ₹8.68 Cr (FY 2025) | ₹72.35 Lakh | 8.3% | -20.0% | Mumbai, Maharashtra, India | |
| Pehal Life Sciences Private Limited | ₹8.66 Cr (FY 2024) | -33.0% | Mumbai, Maharashtra, India | |||
| Waxsen Lifescience Private Limited | ₹8.64 Cr (FY 2019) | -50.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Atilus Pharma Private Limited, buy the company report.
Auditor
Atilus Pharma Private Limited is audited by NIRAJ SANGHAVI & ASSOCIATES for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| NIRAJ SANGHAVI & ASSOCIATES | FY 2024 | 114460 |
Shareholding
The shareholding of Atilus Pharma Private Limited is on record for 3 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Atilus Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹20 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 21 Jun 2022 | 100595718 | Hdfc Bank Limited | ₹20 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
Atilus Pharma Private Limited has 7 court cases on record: 7 filed against it. 2 cases are pending and 5 are disposed.
Total cases
7
Filed against the company
7
Pending
2
Disposed
5
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 7 | 7 | 2 |
Cases on record (5 of 7)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Pune, Maharashtra | Civil suit | Filed against the company by Medlius Pharma Private Limited THR Authorized Signatory Rani Vinod Shiravle | Pending |
| District court, South, Delhi | Cheque dishonour complaint | Filed against the company by Godrej Finance Limited | Pending |
| District court, BENGALURU, Karnataka | Criminal complaint | Filed against the company by M/S Tata Capital Financial Services Ltd | Disposed |
| District court, BENGALURU, Karnataka | Criminal complaint | Filed against the company by M/S Tata Capital Financial Services Ltd | Disposed |
| District court, BENGALURU RURAL, Karnataka | Court case (Com.O.S.) | Filed against the company by M/S Kumar Organic Products Ltd., Rep by Its Authorized Signatory Shivakumar K | Disposed |
To see the full case history of Atilus Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Atilus Pharma Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 12 overdue payments to 8 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 8)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Aariva Pharma Private Limited | |||
| Om Containers Pvt.Ltd. | |||
| Ovoid Pharmachem Private Limited | |||
| an individual supplier | |||
| Perkin Laboratories |
To see the full MSME payment records of Atilus Pharma Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Atilus Pharma Private Limited has 1 active EPFO establishment as of Sep 24, 2025.
Active EPFO establishments
1
GST
Atilus Pharma has 3 GST registrations: 3 active.
Total GSTINs
3
Active
3
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AATCA8813D1ZG | Maharashtra | Active | 31 Aug 2020 |
| 27AATCA8813D2ZF | Maharashtra | Active | 24 Apr 2025 |
| 24AATCA8813D1ZM | Gujarat | Active | 11 Nov 2020 |
To see the full GST registrations and return filing status of Atilus Pharma Private Limited, buy the company report.
Recent activity
Atilus Pharma Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Lomesh Vinod Shah was appointed as Director on 19 Aug 2020.
AGM
Atilus Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Atilus Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 20.00 Lakh with Charge ID 100595718 was registered on 21 Jun 2022.
Appointed
Lomesh Vinod Shah was appointed as Director.
Appointed
Niraj Vinod Shah was appointed as Director.
Incorporation
19 Aug 2020
Atilus Pharma Private Limited was registered on 19 Aug 2020 with Roc Mumbai I & aged 6 years 2 months as per MCA records.
Frequently asked questions
Atilus Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 August 2020 (6+ years old) and is registered under CIN U24110MH2020PTC344095.
Atilus Pharma has 2 current directors:
- Lomesh Vinod Shah - Director
- Niraj Vinod Shah - Director
The latest financial statements of Atilus Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Atilus Pharma is 27AATCA8813D1ZG, registered in Maharashtra. The company has 3 GST registrations in all, of which 3 are active. Other active GSTINs include 27AATCA8813D2ZF (Maharashtra), 24AATCA8813D1ZM (Gujarat).
The CIN (Corporate Identification Number) of Atilus Pharma is U24110MH2020PTC344095. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Atilus Pharma has 7 court cases on record: 7 filed against it. 2 are pending.
Atilus Pharma was incorporated on 19 August 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Atilus Pharma by revenue are Aps Biotech Private Limited, Pehal Life Sciences Private Limited, Waxsen Lifescience Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Lomesh Vinod Shah was appointed as Director on 19 Aug 2020. Niraj Vinod Shah was appointed as Director on 19 Aug 2020.
Yes, Atilus Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-18-0231233).
Atilus Pharma has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 12 overdue payments to 8 micro and small suppliers. The latest return was filed on 30 Apr 2024.
Atilus Pharma can be reached through the website atiluspharma.com. Its registered office is in Mumbai, Maharashtra, India.